Learn how Pradaxa® (dabigatran etexilate capsules) can help lower your risk of stroke due to AFib not caused by a heart valve problem. Read for ISI, Med Guide and PI.
Learn how Pradaxa® (dabigatran etexilate capsules) can help lower your risk of stroke due to AFib not caused by a heart valve problem. Read for ISI, Med Guide and PI.
达比加群酯的适应症和用法用量,达比加群酯(Dabigatran etexilate)适用于:1、非瓣膜性心房颤动的预防性抗凝治疗;2、深静脉血栓形成和肺动脉栓塞的治疗和预防;3、人工心脏瓣膜置换术后的预防性抗凝治疗;4、急性冠状动脉综合症的治疗。达比加群酯(Dabigatran etexilate)推荐剂量为:1、成人通常的推荐剂量为每次150mg,每...
达比加群酯 Dabigatran etexilate Pradaxa 适用于在有非瓣膜性房颤患者中减低卒中和全身性栓塞风险别名: 泰毕全 剂型: 胶囊剂 规格: 75mg*30粒 110mg*30粒 150mg*30粒 厂家: 德国Boehringer Ingelheim 有效期: 24个月 在线咨询 药师回拨
达比加群酯 Dabigatran etexilate Pradaxa 适用于在有非瓣膜性房颤患者中减低卒中和全身性栓塞风险别名: 泰毕全 剂型: 胶囊剂 规格: 75mg*30粒 110mg*30粒 150mg*30粒 厂家: 德国Boehringer Ingelheim 有效期: 24个月 在线咨询 药师回拨
EMEA口服European Human医疗产品委员会近日,欧洲药品评价局( European Medicines Evaluation Agency, EMEA) 下属的欧洲人用医疗产品委员会(The Committee for Medicinal Products in Human Use, CHMP)发布了一份积极的意见,推荐批准勃林格殷格翰公司的口服抗凝血药物 Pradaxa( dabigatran etexilate)上市VIP中国新药杂志...
对 甲磺酸达比加群酯[Dabigatran etexilate mesylate],a 直接凝血酶抑制剂,的化学名is乙基3 - {[(2 - {[(4 - { N ' -己基氧基羰基的氨基甲酰基亚氨基}苯基)氨基]甲基} -1 -甲基-1 H -苯并咪唑-5 -基)羰基](吡啶-2 -基氨基)丙酸乙酯-Alanine,N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]im...
Patient Educationdabigatran etexilate oral DABIGATRAN - ORAL (DA-bi-GAT-ran) COMMON BRAND NAME(S): Pradaxa WARNING: Do not stop taking dabigatran unless directed by your doctor. If you stop taking this medication early, you have a higher risk of forming a serious blood clot (such as ...
1、使用说PRADAXA 甲磺酸达比加群酯 dabigatran etexilate mesylate) 明书2012年12月版处方资料重点这些重点不包括安全和有效使用PRADAX所需所有资料。请参阅下文为PRADAX的完整处方资料PRADAXA?甲磺酸达比加群酯dabigatranetexilate mesylate)胶囊为口服使用美国初始批准:2010最近重大变化(红色为修改部分)剂量和给药方法(...
Pradaxa (Dabigatran Etexilate Mesylate) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.